Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 47, 2018 - Issue 3
333
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Association between cytokine genes polymorphisms and type 1 diabetes: a case-control study on Saudi population

ORCID Icon, , , ORCID Icon, , & show all
Pages 229-240 | Received 04 Sep 2017, Accepted 08 Dec 2017, Published online: 19 Dec 2017

References

  • Aithal G , Day C , Leathart J , et al. (2001). Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn’s disease in a British population. Genes Immun, 2, 44–47. doi:10.1038/sj.gene.6363730.
  • Allam G , Alsulaimani AA , Alghamdi H , et al. (2014). Changes in the levels of cytokines in both diabetic/non-diabetic type i children living in a moderate altitude area in Saudi Arabia. High Alt Med Biol, 15, 380–387.
  • Allam G , Mohamed IA , Alswat KA , et al. (2016). Association of IL‐37 gene polymorphisms with susceptibility to tuberculosis in Saudi subjects. Microbiol Immunol, 60, 778–786.
  • American Diabetes Association . (2015). Classification and diagnosis of diabetes. Diabetes Care, 38, S8–S16.
  • Amim LH , Pacheco AG , Fonseca-Costa J , et al. (2008). Role of IFN-γ+ 874 T/A single nucleotide polymorphism in the tuberculosis outcome among Brazilians subjects. Mol Biol Rep, 35, 563–566.
  • Aminkeng F , Van Autreve JE , Koeleman BP , et al. (2007). TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum Immunol, 68, 690–697.
  • Awatal T , Kuzuyal T , Matsuda A , et al. (1992). Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia, 35, 419–424.
  • Azar ST , Tamim H , Beyhum HN , et al. (1999). Type I (insulin-dependent) diabetes is a Th1-and Th2-mediated autoimmune disease. Clin Diagn Lab Immunol, 6, 306–310.
  • Baharlou R , Ahmadi-Vasmehjani A , Davami MH , et al. (2016). Elevated levels of T-helper 17-associated cytokines in diabetes Type I patients: indicators for following the course of disease. Immunol Invest, 45, 641–651.
  • Barrett JC , Clayton DG , Concannon P , et al. (2009). Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet, 41, 703–707.
  • Baune BT , Konrad C , Grotegerd D , et al. (2012). Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain. J Neuroinflammation, 9, 125.
  • Bazzaz JT , Amoli MM , Taheri Z , et al. (2014). TNF-alpha and IFN-gamma gene variation and genetic susceptibility to type 1 diabetes and its microangiopathic complications. J Diabetes Metab Disord, 13, 46.
  • Bidwell J , Keen L , Gallagher G , et al. (1999). Cytokine gene polymorphism in human disease: on-line databases. Genes Immun, 1, 3–19.
  • Bouqbis L , Akhayat O , Garchon HJ , et al. (2003). TNFA–TNFB haplotypes modify susceptibility to type I diabetes mellitus independently of HLA class II in a Moroccan population. Tissue Antigens, 61, 72–79.
  • Bugawan TL , Mirel DB , Valdes AM , et al. (2003). Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am J Hum Genet, 72, 1505–1514.
  • Burton PR , Clayton DG , Cardon LR , et al. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661–678.
  • Cantagrel A , Navaux F , Loubet‐Lescoulié P , et al. (1999). Interleukin‐1β, interleukin‐1 receptor antagonist, interleukin‐4, and interleukin‐10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum, 42, 1093–1100.
  • Chong WP , Ip WE , Tso GHW , et al. (2006). The interferon gamma gene polymorphism+ 874 A/T is associated with severe acute respiratory syndrome. BMC Infect Dis, 6, 82.
  • De Carvalho PG , De Oliveira Rodrigues R , Ribeiro Da Silva SF , et al. (2016). CD38+CD8+ and CD38+CD4+ T cells and IFN Gamma (+874) polymorphism are associated with a poor virological outcome. Immunol Invest, 45(4), 312–327.
  • Deja G , Jarosz-Chobot P , Polanska J , et al. (2006). Is the association between TNF-α-308 A allele and DMT1 independent of HLA-DRB1. DQB1 Alleles? Mediators Inflamm, 2006, 19724.
  • El-Omar EM , Carrington M , Chow W-H , et al. (2000). Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 404, 398–402.
  • Feng R-N , Li Y , Sun C-H. (2009). TNF 308 G/A polymorphism and type 1 diabetes: a meta-analysis. Diabetes Res Clin Pract, 85, e4–e7.
  • Furuta T , El-Omar EM , Xiao F , et al. (2002). Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology, 123, 92–105.
  • Hamaguchi K , Kimura A , Seki N , et al. (2000). Analysis of tumor necrosis factor‐α promoter polymorphism in type 1 diabetes: HLA‐B and‐DRB1 alleles are primarily associated with the disease in Japanese. Tissue Antigens, 55, 10–16.
  • Harrington LE , Mangan PR , Weaver CT. (2006). Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol, 18, 349–356.
  • Haukim N , Bidwell J , Smith A , et al. (2002). Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun, 3, 313–330.
  • Hollegaard M , Bidwell J. (2006). Cytokine gene polymorphism in human disease: on-line databases, supplement 3. Genes Immun, 7, 269–276.
  • Huang C-M , Wu M-C , Wu J-Y , et al. (2002). No association of interleukin-4 gene polymorphisms in Chinese patients with rheumatoid arthritis in Taiwan. Clin Exp Rheumatol, 20, 871–872.
  • Ichinose K , Kawasaki E , Eguchi K . (2007). Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy. Am J Nephrol, 27, 554–564.
  • International Diabetes Federation . (2015). Diabetes Atlas, 7th Edn. Brussels, Belgium: International Diabetes Federation. http://www.idf.org/idf-diabetes-atlas-seventh-edition.
  • Javor J , Ferencik S , Bucova M , et al. (2010). Polymorphisms in the genes encoding TGF-β1, TNF-α, and IL-6 show association with type 1 diabetes mellitus in the Slovak population. Arch Immunol Ther Exp (Warsz), 58, 385–393.
  • Kallmann BA , Hüther M , Feldkamp J , et al. (1997). Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves’ disease. Diabetes, 46, 237–243.
  • Kawashima T , Noguchi E , Arinami T , et al. (1998). Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet, 35, 502–504.
  • Kristiansen OP , Pociot F , Johannesen J , et al. (2000). Linkage disequilibrium testing of four interleukin-1 gene-cluster polymorphisms in Danish multiplex families with insulin-dependent diabetes mellitus. Cytokine, 12, 171–175.
  • Kroeger KM , Carville KS , Abraham LJ . (1997). The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol, 34, 391–399.
  • Li N , He Z , Xu J , et al. (2010). Association of PDE4D and IL-1 gene polymorphism with ischemic stroke in a Han Chinese population. Brain Res Bull, 81, 38–42.
  • López-Maderuelo D , Arnalich F , Serantes R , et al. (2003). Interferon-γ and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med, 167, 970–975.
  • Maier LM , Chapman J , Howson JM , et al. (2005). No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes. Am J Hum Genet, 76, 517–521.
  • Mandrup-Poulsen T . (1996). The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia, 39, 1005–1029.
  • Mauricio D , Mandrup-Poulsen T . (1998). Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes, 47, 1537–1543.
  • Moreno O , González CI , Saaibi DL , et al. (2007). Polymorphisms in the IL4 and IL4RA genes in Colombian patients with rheumatoid arthritis. J Rheumatol, 34, 36–42.
  • Noble JA , Valdes AM , Lane JA , et al. (2006). Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-α polymorphisms on type 1 diabetes susceptibility. Hum Immunol, 67, 999–1004.
  • Nuñez C , Santiago JL , Varadé J , et al. (2008). IL4 in the 5q31 context: association studies of type 1 diabetes and rheumatoid arthritis in the Spanish population. Immunogenetics, 60, 19–23.
  • Olavesen M , Hampe J , Mirza MM , et al. (2000). Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease. Immunogenetics, 51, 1–7.
  • Pawlik A , Wrzesniewska J , Florczak M , et al. (2005). The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int, 26, 48–51.
  • Pociot F , Akolkar B , Concannon P , et al. (2010). Genetics of type 1 diabetes: what’s next? Diabetes, 59, 1561–1571.
  • Pociot F , Mølvig J , Wogensen L , et al. (1992). A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro. Eur J Clin Invest, 22, 396–402.
  • Pravica V , Perrey C , Stevens A , et al. (2000). A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol, 61, 863–866.
  • Qiu LJ , Ni J , Cen H , et al. (2015). Relationship between the IL‐4 gene promoter ‐590C/T (rs2243250) polymorphism and susceptibility to autoimmune diseases: a meta‐analysis. J Eur Acad Dermatol Venereol, 29, 48–55.
  • Rabinovitch A . (1998). An update on cytokines in the pathogenesis of insulin‐dependent diabetes mellitus. Diabetes Metab Rev, 14, 129–151.
  • Rapoport M , Mor A , Vardi P , et al. (1998). Decreased secretion of Th2 cytokines precedes up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. J Autoimmun, 11, 635–642.
  • Rosenwasser LJ , Borish L . (1997). Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med, 156, S152–S155.
  • Shin HD , Yang SW , Kim DH , et al. (2008). Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility. Ann N Y Acad Sci, 1150, 76–85.
  • Sivula J , Turpeinen H , Volin L , et al. (2009). Association of IL-10 and IL-10Rβ gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor. BMC Immunol, 10, 24.
  • Smith AJ , Humphries SE . (2009). Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev, 20, 43–59.
  • Srinivas L , Vellichirammal NN , Alex AM , et al. (2016). Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia. J Neuroinflammation, 13, 105.
  • Stojanova J , Pouché L , Picard N . (2016). Genetic polymorphisms in the immune response: a focus on kidney transplantation. Clin Biochem, 49, 363–376.
  • Talaat I , Nasr A , Alsulaimani A , et al. (2016). Association between type 1, type 2 cytokines, diabetic autoantibodies and 25-hydroxyvitamin D in children with type 1 diabetes. J Endocrinol Invest, 39, 1425–1434.
  • Todd JA , Walker NM , Cooper JD , et al. (2007). Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet, 39, 857–864.
  • Wang N , Yin D , Zhang S , et al. (2012). TNF-alpha rs1800629 polymorphism is not associated with HPV infection or cervical cancer in the Chinese population. PLoS One, 7, e45246.
  • Wilson AG , Symons JA , McDowell TL , et al. (1997). Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci U S A, 94, 3195–3199.
  • Yamagata K , Nakajima H , Tomita K , et al. (1996). Dominant TCR α-chain clonotypes and interferon-γ are expressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitus. Diabetes Res Clin Pract, 34, 37–46.
  • Yoon J-W , Jun H-S . (2005). Autoimmune destruction of pancreatic β cells. Am J Ther, 12, 580–591.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.